Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?

By Kumar N.B.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 2, 1997-06 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Decreased prostate cancer cell migration by inhibition of the insulin-like growth factor II/Mannose-6-Phosphate receptor - A receptor saturation mechanism to increase the secretion of lysosomal proenzymes

By Evans C.P.   Elfman F.   Cunha G.   Shuman M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 5, 1997-09 ,pp. : 166-170

Elsevier

Access to resources Recommend Favorite

Oestrogen Receptor-Mediated Modulation of the EGFR/MAPK Pathway in Tamoxifen-Resistant MCF-7 Cells

By Hutcheson I.R.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-09 ,pp. : 81-93

Springer Publishing Company

Access to resources Recommend Favorite

Increased Constitutive Activity of PKB/Akt in Tamoxifen Resistant Breast Cancer MCF‐7 Cells

By Jordan Nicola J.  

Breast Cancer Research and Treatment, Vol. 87, Iss. 2, 2004-09 ,pp. : 167-180

Springer Publishing Company

Access to resources Recommend Favorite

Hepatic toxicity caused by adjuvant CMF/CNF in breast cancer patients and reversal by tamoxifen

By Hirvikoski P.P.   Kumpulainen E.J.   Johansson R.T.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite